These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2828746)

  • 1. Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo.
    Ura N; Carretero OA; Erdös EG
    Kidney Int; 1987 Oct; 32(4):507-13. PubMed ID: 2828746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of various rat plasma peptidases to kinin hydrolysis.
    Ishida H; Scicli AG; Carretero OA
    J Pharmacol Exp Ther; 1989 Dec; 251(3):817-20. PubMed ID: 2557417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A sensitive method for differential determination of kininase I, II and neutral endopeptidase (NEP) in human urine.
    Ogata H; Ura N; Shimamoto K; Sakakibara T; Ando T; Nishimiya T; Nakagawa M; Fukuyama S; Masuda A; Yamaguchi Y
    Adv Exp Med Biol; 1989; 247B():343-8. PubMed ID: 2558508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible involvement of placental proteases in bradykinin (BK) degradation.
    Kuno N; Mizutani S; Ohno Y; Goto K; Itakura A; Kondo I; Kurauchi O; Kikkawa F; Tomoda Y
    Reprod Fertil Dev; 1997; 9(6):633-9. PubMed ID: 9551668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of combined neutral endopeptidase 24-11 and angiotensin-converting enzyme inhibition on femoral vascular conductance in streptozotocin-induced diabetic rats.
    Arbin V; Claperon N; Fournié-Zaluski MC; Roques BP; Peyroux J
    Br J Pharmacol; 2000 Jul; 130(6):1297-304. PubMed ID: 10903969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potentiation of bradykinin effect by angiotensin-converting enzyme inhibition does not correlate with angiotensin-converting enzyme activity in the rat mesenteric arteries.
    Sivieri DO; Bispo-da-Silva LB; Oliveira EB; Resende AC; Salgado MC
    Hypertension; 2007 Jul; 50(1):110-5. PubMed ID: 17470724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of kinins and atrial natriuretic peptide on the renal effects of neutral endopeptidase inhibitor in rats.
    Ura N; Shimamoto K; Kuroda S; Nomura N; Iwata M; Aoyama T; Iimura O
    Clin Exp Hypertens; 1994 Nov; 16(6):799-808. PubMed ID: 7858560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the renin-angiotensin-aldosterone and kallikrein-kinin systems in the control of fluid and electrolyte metabolism, renal function, and arterial blood pressure.
    McCaa RE
    Clin Exp Hypertens A; 1982; 4(9-10):1593-611. PubMed ID: 6754146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of angiotensin converting enzyme and other peptidases in in vivo metabolism of kinins.
    Ishida H; Scicli AG; Carretero OA
    Hypertension; 1989 Sep; 14(3):322-7. PubMed ID: 2548961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutral endopeptidase and angiotensin converting enzyme inhibitors potentiate kinin-induced contraction of ferret trachea.
    Dusser DJ; Nadel JA; Sekizawa K; Graf PD; Borson DB
    J Pharmacol Exp Ther; 1988 Feb; 244(2):531-6. PubMed ID: 3279179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renal kininases in primary aldosteronism.
    Ura N; Shimamoto K; Ogata H; Sakakibara T; Ando T; Fukuyama S; Nakagawa M; Saito S; Tanaka S; Iimura O
    Adv Exp Med Biol; 1989; 247B():145-50. PubMed ID: 2558506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bradykinin degrading activity in cultured human endothelial cells.
    Graf K; Gräfe M; Auch-Schwelk W; Baumgarten CR; Bossaller C; Fleck E
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S16-20. PubMed ID: 1282624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of angiotensin-converting enzyme inhibition on circulating and local kinin levels.
    Johnston CI; Clappison BH; Anderson WP; Yasujima M
    Am J Cardiol; 1982 Apr; 49(6):1401-4. PubMed ID: 6122371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natriuretic mechanisms of neutral endopeptidase inhibitor in rats.
    Shimamoto K; Ura N; Iimura O
    Braz J Med Biol Res; 1994 Aug; 27(8):1965-73. PubMed ID: 7749388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
    Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of bradykinin agonists and antagonists by plasma aminopeptidase P.
    Ward PE; Chow A; Drapeau G
    Biochem Pharmacol; 1991 Jul; 42(4):721-7. PubMed ID: 1651078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disappearance of bradykinin in the renal circulation of dogs. Effects of kininase inhibition.
    Nasjletti A; Colina-Chourio J; McGiff JC
    Circ Res; 1975 Jul; 37(1):59-65. PubMed ID: 167999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal tubular responsiveness to atrial natriuretic peptide in sodium-retaining chronic caval dogs. A possible role for kinins and luminal actions of the peptide.
    Legault L; Cernacek P; Levy M; Maher E; Farber D
    J Clin Invest; 1992 Oct; 90(4):1425-35. PubMed ID: 1328299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.